118 related articles for article (PubMed ID: 9721248)
1. trans E1 component requirements for maximal replication of E1-defective recombinant adenovirus.
Goldsmith KT; Dion LD; Curiel DT; Garver RI
Virology; 1998 Sep; 248(2):406-19. PubMed ID: 9721248
[TBL] [Abstract][Full Text] [Related]
2. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
3. Control of p53 expression by adenovirus 12 early region 1A and early region 1B 54K proteins.
Grand RJ; Owen D; Rookes SM; Gallimore PH
Virology; 1996 Apr; 218(1):23-34. PubMed ID: 8615026
[TBL] [Abstract][Full Text] [Related]
4. E1A RNA transcripts amplify adenovirus-mediated tumor reduction.
Dion LD; Goldsmith KT; Strong TV; Bilbao G; Curiel DT; Garver RI
Gene Ther; 1996 Nov; 3(11):1021-5. PubMed ID: 9044743
[TBL] [Abstract][Full Text] [Related]
5. Complementation of a defective human adenovirus by an otherwise incompatible ovine adenovirus recombinant carrying a functional E1A gene.
Lockett LJ; Both GW
Virology; 2002 Mar; 294(2):333-41. PubMed ID: 12009875
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and in vivo activity of adenoviral-producing cells made by cotransduction of a replication-defective adenovirus and a replication-enabling plasmid.
Dion LD; Goldsmith KT; Garver RI
Cancer Gene Ther; 1996; 3(4):230-7. PubMed ID: 8853547
[TBL] [Abstract][Full Text] [Related]
7. Decreased replication ability of E1-deleted adenoviruses correlates with increased brain tumor malignancy.
Ghosh S; Duigou GJ
Cancer Res; 2005 Oct; 65(19):8936-43. PubMed ID: 16204066
[TBL] [Abstract][Full Text] [Related]
8. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
9. Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors.
Howe JA; Pelka P; Antelman D; Wilson C; Cornell D; Hancock W; Ramachandra M; Avanzini J; Horn M; Wills K; Sutjipto S; Ralston R
Virology; 2006 Feb; 345(1):220-30. PubMed ID: 16246392
[TBL] [Abstract][Full Text] [Related]
10. Analysis of early region 1 of porcine adenovirus type 3.
Zhou Y; Tikoo SK
Virology; 2001 Dec; 291(1):68-76. PubMed ID: 11878877
[TBL] [Abstract][Full Text] [Related]
11. Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes.
Steinwaerder DS; Carlson CA; Lieber A
Mol Ther; 2001 Sep; 4(3):211-6. PubMed ID: 11545611
[TBL] [Abstract][Full Text] [Related]
12. Infectivity and expression of the early adenovirus proteins are important regulators of wild-type and DeltaE1B adenovirus replication in human cells.
Steegenga WT; Riteco N; Bos JL
Oncogene; 1999 Sep; 18(36):5032-43. PubMed ID: 10490840
[TBL] [Abstract][Full Text] [Related]
13. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
Rao XM; Tseng MT; Zheng X; Dong Y; Jamshidi-Parsian A; Thompson TC; Brenner MK; McMasters KM; Zhou HS
Cancer Gene Ther; 2004 Sep; 11(9):585-93. PubMed ID: 15338010
[TBL] [Abstract][Full Text] [Related]
14. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
Hoffmann D; Jogler C; Wildner O
J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
[TBL] [Abstract][Full Text] [Related]
15. Characterization of bovine adenovirus type 3 E1 proteins and isolation of E1-expressing cell lines.
van Olphen AL; Tikoo SK; Mittal SK
Virology; 2002 Mar; 295(1):108-18. PubMed ID: 12033770
[TBL] [Abstract][Full Text] [Related]
16. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy.
Rancourt C; Piché A; Gomez-Navarro J; Wang M; Alvarez RD; Siegal GP; Fuller GM; Jones SA; Curiel DT
Clin Cancer Res; 1999 Jan; 5(1):43-50. PubMed ID: 9918201
[TBL] [Abstract][Full Text] [Related]
18. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.
Zheng X; Rao XM; Snodgrass CL; McMasters KM; Zhou HS
Cancer Gene Ther; 2006 Jun; 13(6):572-83. PubMed ID: 16341141
[TBL] [Abstract][Full Text] [Related]
19. p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma.
Vollmer CM; Ribas A; Butterfield LH; Dissette VB; Andrews KJ; Eilber FC; Montejo LD; Chen AY; Hu B; Glaspy JA; McBride WH; Economou JS
Cancer Res; 1999 Sep; 59(17):4369-74. PubMed ID: 10485485
[TBL] [Abstract][Full Text] [Related]
20. A novel targeting modality to enhance adenoviral replication by vitamin D(3) in androgen-independent human prostate cancer cells and tumors.
Hsieh CL; Yang L; Miao L; Yeung F; Kao C; Yang H; Zhau HE; Chung LW
Cancer Res; 2002 Jun; 62(11):3084-92. PubMed ID: 12036918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
